Pharmacist-Patient RelationsNCT05416892
What is the Impact of Implementing Pharmaceutical Algorithms in the PharmaClass® Software, on the Handling the Patient's Medication Load, by the Clinical Pharmacist?
An observational study of Pharmacist-Patient Relations, run by Murielle Surquin at 1 site in Belgium.
Trial summary
The clinical pharmacists present in the hospitalisation units aim to ensure the daily review of the drug prescriptions of hospitalized patients. In order to optimize their work, the objective of this study would be to provide them with a clinical decision support tool via artificial intelligence in order to improve… Read more about this study
- Who is it for?
- Ages 75 years and older
- Conditions the study is for
- Pharmacist-Patient Relations
- What is being tested?
- Pharmaclass® software
- How many people
- 109 participants
- Where
- 1 siteBelgium
- Study dates
- 14 Sep 2021to 1 Apr 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 75 years and older
- All sexes
- No healthy volunteers
- Older adult
Study population: Hospitalized patient entering the SU06 or SU13 geriatrics unit of the Paul Brien site of the CHU Brugmann Hospital between November 16 2021 and April 15, 2022
Who may be able to join
- Hospitalized patient entering the SU06 or SU13 geriatrics unit of the Paul Brien site of the CHU Brugmann Hospital between November 16 2021 and April 15, 2022
- Speaking French and/or Dutch
- With chronic renal failure or taking at least one medicine for diabetes, heart, COPD, asthma, high blood pressure, epilepsy, atrial fibrillation, osteoporosis, high cholesterol, pain, parkinsonism, blood clotting, constipation, thyroid, depression, benign prostatic hypertrophy, gastric ulcer, Alzheimer's disease, cirrhosis as well as for electrolyte disorders (hypo or hypernatremia / potassium / calcium/magnesemia/phosphatemia).
Who cannot join
- Patient who died or was transferred to another care unit during his/her hospitalization
Trial locations and contacts
1 site in 1 country.
About this study
Official title: What is the Impact of Implementing Pharmaceutical Algorithms in the PharmaClass® Software, on the Handling the Patient's Medication Load, by the Clinical Pharmacist? Analysis of These Impacts Within 2 Geriatric Units of the CHU Brugmann Hospital
The clinical pharmacists present in the hospitalisation units aim to ensure the daily review of the drug prescriptions of hospitalized patients.
In order to optimize their work, the objective of this study would be to provide them with a clinical decision support tool via artificial intelligence in order to improve the patient's medication management. This study will test the Pharmaclass® software.
- Conditions
- Pharmacist-Patient Relations
- Being tested
- Pharmaclass® software
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pharmaclass® softwareOther
Clinical decision support tool via artificial intelligence in order to improve the patient's medication management.
| Study group | Role | What they receive |
|---|---|---|
| Patients of Geriatric Wards SU06 and SU13 of the CHU Brugmann Hospital | Not described Receives: Other: Pharmaclass® software |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time
Time required to perform an intervention (pharmacist versus software)
Measured: 5 months
Dosage compliance
Dosage compliance with existing recommendations and laboratory results/clinical parameters (pharmacist versus software)
Measured: 5 months
Medication error severity
Severity of the medication error that could be avoided (pharmacist versus software)
Measured: 5 months
Geriatrician approval
Number of interventions validated/refused by the geriatrician (pharmacist versus software)
Measured: 5 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jun 2022
- Study start14 Sep 2021
- Primary completion1 Apr 2022
- Study completion1 Apr 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pharmacist-Patient RelationsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 109 participants (actual)
Sponsor and investigators
- Lead sponsor
- Murielle Surquin
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Murielle Surquin, Brugmann University Hospital
- Investigators
- Charline DANNEEL, Principal investigator, CHU Brugmann
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05416892
- Sponsor's protocol ID
- CHUB-PharmaClass
- Status last verified
- Jun 2022
- First submitted
- 9 Jun 2022
- Last updated
- 14 Jun 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Jun 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- What is the Impact of Implementing Pharmaceutical Algorithms in the PharmaClass® Software, on the Handling the Patient's Medication Load, by the Clinical Pharmacist? Analysis of These Impacts Within 2 Geriatric Units of the CHU Brugmann Hospital
- ClinicalTrials.gov ID
- NCT05416892
- Acronym / sponsor ID
- CHUB-PharmaClass
- Conditions
- Pharmacist-Patient Relations
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 109 participants (actual)
- Lead sponsor
- Murielle SurquinUniversity, hospital or other
- Study start
- 14 Sep 2021 (actual)
- Primary completion
- 1 Apr 2022 (actual)
- Study completion
- 1 Apr 2022 (actual)
- First posted
- 14 Jun 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The clinical pharmacists present in the hospitalisation units aim to ensure the daily review of the drug prescriptions of hospitalized patients.
In order to optimize their work, the objective of this study would be to provide them with a clinical decision support tool via artificial intelligence in order to improve the patient's medication management. This study will test the Pharmaclass® software.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients of Geriatric Wards SU06 and SU13 of the CHU Brugmann Hospital | – | Other: Pharmaclass® software |
Who may qualify
- Ages
- 75 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- Hospitalized patient entering the SU06 or SU13 geriatrics unit of the Paul Brien site of the CHU Brugmann Hospital between November 16 2021 and April 15, 2022
Key inclusion criteria (3 listed)
- Hospitalized patient entering the SU06 or SU13 geriatrics unit of the Paul Brien site of the CHU Brugmann Hospital between November 16 2021 and April 15, 2022
- Speaking French and/or Dutch
- With chronic renal failure or taking at least one medicine for diabetes, heart, COPD, asthma, high blood pressure, epilepsy, atrial fibrillation, osteoporosis, high cholesterol, pain, parkinsonism, blood clotting, constipation, thyroid, depression, benign prostatic hypertrophy, gastric ulcer, Alzheimer's disease, cirrhosis as well as for electrolyte disorders (hypo or hypernatremia / potassium / calcium/magnesemia/phosphatemia).
Key exclusion criteria (1 listed)
- Patient who died or was transferred to another care unit during his/her hospitalization
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pharmaclass® softwareClinical decision support tool via artificial intelligence in order to improve the patient's medication management. | Other | Patients of Geriatric Wards SU06 and SU13 of the CHU Brugmann Hospital |
Primary outcome
Time
Time frame: 5 months
Time required to perform an intervention (pharmacist versus software)
Dosage compliance
Time frame: 5 months
Dosage compliance with existing recommendations and laboratory results/clinical parameters (pharmacist versus software)
Medication error severity
Time frame: 5 months
Severity of the medication error that could be avoided (pharmacist versus software)
Geriatrician approval
Time frame: 5 months
Number of interventions validated/refused by the geriatrician (pharmacist versus software)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jun 2022.
- Individual participant dataSharing planned: No
Related trials for Pharmacist-Patient Relations
Active, not recruiting
Healthy Opioid Prescription Engagement
Opioid Misuse, Opioid-Related Disorders
Active, not recruiting
Factors Determining the Rate of Adoption of Pharmaceutical Recommendations by Patients in Primary Care Following a Medication Review by a Pharmacist
Polypharmacy (People Under Treatment With 5 or More Drugs), Polypharmacy, Decision-making
Not yet recruiting
A Study to Investigate Health Related Quality of Life With a Pharmacist Intervention Compared to Treatment as Usual in Participants With Severe Mental Illness and Substance Use Disorder Receiving Treatment From FACT Teams.
Severe Mental Illness, Substance Use Disorder (SUD)
Enrolling by invitation
Improving Medication Therapy Through a Digital Interdisciplinary Medicine Therapy Optimisation Model
Medication-related Problems, Self-reported Medication Adherence
Not yet recruitingObservational study
Association Between Geriatric Frailty and Medication Related Problems in the Emergency Department to Help Clinical Pharmacists Prioritise Patients
Frailty, Emergency Department Visit
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Charline DANNEEL principal investigator
CHU Brugmann
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pharmacist-Patient Relations, run by Murielle Surquin at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time (time frame: 5 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jun 2022.